A AddLife AB
A
Gesloten
158.4 -1.8
Overzicht
Wijziging aandelenprijs
24u
Min
156.2
Max
161.9
Inkomsten | -31M 229M |
|---|---|
Verkoop | -88M 2.6B |
K/W Sectorgemiddelde | 33.72 99.973 |
EPS | 1.04 |
Dividendrendement | 0.95 |
Winstmarge | 8.658 |
Werknemers | 2,295 |
EBITDA | -373M 229M |
Dividendrendement Sectorgemiddelde | 0.95% 2.44% |
|---|
Marktkapitalisatie | 1.5B 19B |
|---|---|
Vorige openingsprijs | 160.2 |
Vorige sluitingsprijs | 158.4 |
AddLife AB Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.